Skip to main content

Vbi Vaccines Inc CS(VBIV-Q)

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Vbi Vaccines Inc CS

160 Second Street Floor 3
Cambridge MA 02142 USA
P: 617-830-3031

Sectors & Indices



    VBI Vaccines Inc. is a biopharmaceutical company developing novel technologies to expand vaccine protection. The company's eVLP vaccine platform allows for the design of enveloped virus-like particle vaccines which closely mimic the target virus. Its lead eVLP asset is a prophylactic cytomegalovirus vaccine. Its second platform is a thermostable technology that enables the development of vaccines and biologics. VBI Vaccines Inc., formerly known as SciVac Therapeutics, Inc., is headquartered in Cambridge, MA.

    Key Executives

    Avi MazaltovGeneral Manager, Subsidiary/Other Corporate Officer
    Jeffrey R. BaxterCEO/Director/President
    David E. AndersonChief Scientific Officer
    Nell BeattieCFO/Director/Other Corporate Officer
    Francisco Diaz-MitomaChief Medical Officer
    John Robert DillmanOther Executive Officer